Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2010
09/30/2010WO2010110737A1 Monoclonal antibody against a conserved domain of m2e polypeptide in influenza viruses
09/30/2010WO2010110455A1 Polyion complex comprising hydrophobized polyamino acid and use of same
09/30/2010WO2010110440A1 Novel therapeutic agent for cognitive impairment
09/30/2010WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative
09/30/2010WO2010109418A1 A medicinal antifungal cream and a process to make it
09/30/2010WO2010109284A1 Antimicrobial cationic lipo-beta-peptides
09/30/2010WO2010108977A1 Vaccine for protection against streptococcus suis bacteria of various serotypes
09/30/2010WO2010108417A1 Method for preparing acyclovir 2/3 hydrate
09/30/2010WO2010108410A1 Use of catechin in preparation of retrovirus integrase inhibitor
09/30/2010WO2010091373A3 Trimerich hiv fusion inhibitors for treating or preventing hiv infection
09/30/2010WO2010089510A3 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
09/30/2010WO2010075376A3 Anti-viral compounds
09/30/2010WO2010068714A3 Deuterated compounds as hepatitis c virus (hcv) inhibitors
09/30/2010WO2010043977A3 Dengue virus neutralizing antibodies and uses thereof
09/30/2010US20100251397 Polyploid castor plants, compositions derived therefrom and uses of same
09/30/2010US20100249747 Transdermal venous access locking solution
09/30/2010US20100249247 Antimicrobial compositions
09/30/2010US20100249230 Antiviral activity of cyclopentene nitro-ester and derivatives
09/30/2010US20100249214 Multiplex dicer substrate rna interference molecules having joining sequences
09/30/2010US20100249212 Gene Silencing Using mRNA-cDNA Hybrids
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100249190 Hepatitis C Virus Inhibitors
09/30/2010US20100249189 Nitric oxide donor compounds
09/30/2010US20100249185 Method for inhibiting topoisomerase ii
09/30/2010US20100249183 Therapeutic use of n-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives
09/30/2010US20100249156 Antiviral topical formulations in the form of a bio-adhesive gel
09/30/2010US20100249149 Inhibitors of Protein Kinases
09/30/2010US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
09/30/2010US20100249122 Kinase Inhibitors for Preventing or Treating Pathogen Infection and Method of Use Thereof
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010US20100249094 Compounds for the Treatment of Hepatitis C
09/30/2010US20100249076 Prodrugs of 9-aminomethyl tetracycline compounds
09/30/2010US20100249068 Substituted nucleoside and nucleotide analogs
09/30/2010US20100249058 Feed additive and feed
09/30/2010US20100249051 Bioactive Molecules from Co-Cultivation of Microbes
09/30/2010US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
09/30/2010US20100249022 Strategy for cloning and expressing the extracellular domains of receptors as soluble proteins
09/30/2010US20100249021 Method and medicament for inhibiting the infection of influenza virus
09/30/2010US20100249019 Use of a peptide as a therapeutic agent
09/30/2010US20100249017 Use of cnp-22, alone or in combination with physalemin, as a therapeutic agent
09/30/2010US20100249016 Metal-binding compounds and uses therefor
09/30/2010US20100247694 Composition and method for treament of inflamation and infections of the outer ear canal, nose and paranasal sinuses
09/30/2010US20100247691 Anti-angiogenic agents and anti-obesity substances applied with anti-angiogenesis from natural products
09/30/2010US20100247688 Pirenzepine and derivatives thereof as anti-amyloid agents
09/30/2010US20100247685 Methods For Treating and Reducing the Incidence of Newcastle Disease
09/30/2010US20100247661 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
09/30/2010US20100247648 Antimicrobial compounds
09/30/2010US20100247635 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
09/30/2010US20100247629 Method for drug loading in liposomes
09/30/2010US20100247625 Orally Bioavailable Lipid-Based Constructs
09/30/2010US20100247624 Vaccine compositions and methods containing an immunogen derived from equine arteritis virus
09/30/2010US20100247618 Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
09/30/2010US20100247600 Therapeutic drug eluting implant cover and method of making the same
09/30/2010US20100247590 Peptide-Based Systems For Delivery Of Cosmetic Agents
09/30/2010US20100247587 Pigmentation-regulating compounds
09/30/2010US20100247575 Agents for promoting iga production
09/30/2010US20100247574 CHIMERIC NEWCASTLE DISEASE VIRUS VLPs
09/30/2010US20100247573 Stabilization of Vaccines by Lyophilization
09/30/2010US20100247571 Methods and compositions for immunization against virus
09/30/2010US20100247570 High Mannose Glycoprotein Epitopes
09/30/2010US20100247569 Influenza A Virus Vaccines and Inhibitors
09/30/2010US20100247567 Composition and method for controlling intestinal pathogenic organisms
09/30/2010US20100247566 Cholera vaccines
09/30/2010US20100247565 Chimeric sindbis-eastern equine encephalitis virus and uses thereof
09/30/2010US20100247564 Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
09/30/2010US20100247561 Polypeptides for inducing a protective immune response against staphylococcus aureus
09/30/2010US20100247558 PEPTIDES INDUCING A CD4i CONFORMATION IN HIV gp120 WHILE RETAINING VACANT CD4 BINDING SITE
09/30/2010US20100247555 Reversibly inhibited antibodies for immune cell stimulation
09/30/2010US20100247554 Use of tam receptor inhibitors as antimicrobials
09/30/2010US20100247550 Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
09/30/2010US20100247549 Monoclonal antibodies against dengue and other viruses with deletion in fc region
09/30/2010US20100247546 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/30/2010US20100247544 Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms
09/30/2010US20100247535 Chemically Programmable Immunity
09/30/2010US20100247532 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies
09/30/2010US20100247525 Compositions and methods for treating anthrax lethality
09/30/2010US20100247523 Subtypes of humanized antibody against interleuken-6 receptor
09/30/2010US20100247522 Linked purine pterin hppk inhibitors useful as antibacterial agents
09/30/2010US20100247508 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
09/30/2010US20100247490 SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38
09/30/2010US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds
09/30/2010US20100247463 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
09/30/2010US20100247461 Anti-inflammatory complexes
09/30/2010US20100247455 Periodontal Bacterial Growth Inhibitor, Oral Hygiene Product, and Food and Drink
09/30/2010US20100247447 Drug delivery system for hydrophobic drugs
09/30/2010US20100247431 Polypeptides including modified constant regions
09/30/2010DE102009015461A1 New O-acylated hydroxycarboxylic acid-polyol compounds obtained from O-acylated hydroxycarboxylic acid- and polyol-compound, useful e.g. to treat microbial diseases, preferably bacteria, virus and/or fungi/mold spores, and as food additive
09/30/2010CA2756883A1 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
09/30/2010CA2756769A1 Fluoroquinolone carboxylic acid molecular crystals
09/30/2010CA2756412A1 Compositions for stimulation of mammalian innate immune resistance to pathogens
09/30/2010CA2756206A1 Methods and compositions for immunization against virus
09/30/2010CA2756172A1 Inhibitors of hepatitis c virus replication
09/30/2010CA2755348A1 Antiviral compounds and uses thereof
09/30/2010CA2755023A1 Antiviral compounds and uses thereof
09/30/2010CA2754691A1 Dry powder formulations and methods for treating pulmonary diseases
09/30/2010CA2754416A1 Novel medicament for treating cognitive impairment
09/29/2010EP2233575A1 An anti-hcv vaccine and preparation methods and uses thereof
09/29/2010EP2233498A1 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same
09/29/2010EP2233495A1 Glycosylated glycopeptide antibiotic derivative
1 ... 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 ... 1798